Skip to main content


"There is concern that with a license for multiple sclerosis, the cost of alemtuzumab could rise and might become too expensive for many patients and health systems," an editorial in the medical journal the Lancet warns.
872 of 1855

Newsletter Sign Up

Daily Readings

Reading 1, Romans 1:16-25
For I see no reason to be ashamed of the gospel; it is God's ... Read More

Psalm, Psalms 19:2-3, 4-5
day discourses of it to day, night to night hands on the ... Read More

Gospel, Luke 11:37-41
He had just finished speaking when a Pharisee invited him to ... Read More

Saint of the Day

October 13 Saint of the Day

St. Edward the Confessor
October 13: Edward the Confessor was the son of King Ethelred III and ... Read More